Janney Montgomery Scott LLC Increases Position in Oscar Health, Inc. $OSCR

Key Points

• Janney Montgomery Scott LLC increased its holdings in Oscar Health by 32%, owning 71,152 shares valued at $1,525,000 by the end of the 2nd quarter.
• Oscar Health's stock has experienced analyst downgrades, with Robert W. Baird reducing its price target from $28 to $14 and multiple analysts rating it as a Sell.
• Insider Mario Schlosser sold 395,000 shares at an average price of $18.43, reducing his ownership by 44.08%.

Janney Montgomery Scott LLC raised its holdings in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 32.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 71,152 shares of the company's stock after purchasing an additional 17,245 shares during the quarter. Janney Montgomery Scott LLC's holdings in Oscar Health were worth $1,525,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Jones Financial Companies Lllp boosted its holdings in Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock valued at $30,000 after purchasing an additional 2,242 shares during the last quarter. Strs Ohio acquired a new stake in Oscar Health in the 1st quarter valued at about $30,000. Larson Financial Group LLC raised its holdings in Oscar Health by 83,733.3% in the 1st quarter. Larson Financial Group LLC now owns 2,515 shares of the company's stock valued at $33,000 after acquiring an additional 2,512 shares during the last quarter. CWM LLC raised its holdings in Oscar Health by 50.7% in the 1st quarter. CWM LLC now owns 3,204 shares of the company's stock valued at $42,000 after acquiring an additional 1,078 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd raised its holdings in Oscar Health by 484.6% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company's stock valued at $45,000 after acquiring an additional 2,854 shares during the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

OSCR has been the subject of several analyst reports. Robert W. Baird reissued a "neutral" rating and issued a $14.00 price target (down previously from $28.00) on shares of Oscar Health in a research note on Friday, July 25th. Baird R W cut shares of Oscar Health from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 25th. Wall Street Zen cut shares of Oscar Health from a "hold" rating to a "sell" rating in a research report on Saturday, August 9th. Piper Sandler reduced their price objective on shares of Oscar Health from $14.00 to $13.00 and set a "neutral" rating on the stock in a report on Thursday, August 14th. Finally, Wells Fargo & Company lifted their price target on shares of Oscar Health from $10.00 to $14.00 and gave the stock an "underweight" rating in a research note on Tuesday. Four investment analysts have rated the stock with a Hold rating and six have assigned a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Strong Sell" and an average target price of $12.64.

Insider Buying and Selling

In related news, insider Mario Schlosser sold 395,000 shares of the business's stock in a transaction dated Monday, September 22nd. The shares were sold at an average price of $18.43, for a total transaction of $7,279,850.00. Following the sale, the insider owned 501,148 shares of the company's stock, valued at approximately $9,236,157.64. The trade was a 44.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 24.39% of the company's stock.

Oscar Health Trading Down 8.4%

Shares of Oscar Health stock opened at $18.81 on Friday. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.80. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 0.86. The company has a market capitalization of $4.86 billion, a P/E ratio of -23.22 and a beta of 1.89. The company's fifty day moving average is $17.77 and its two-hundred day moving average is $15.86.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, beating the consensus estimate of ($0.90) by $0.01. The business had revenue of $2.86 billion for the quarter, compared to the consensus estimate of $2.88 billion. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The business's quarterly revenue was up 29.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.20 earnings per share. Analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.